| Dr Daniel Lee Smugor, DPM, PHARMD | |
|
8313 Oasis Ln, Knoxville, TN 37938-7400 | |
| (865) 377-3174 | |
| Not Available |
| Full Name | Dr Daniel Lee Smugor |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 8313 Oasis Ln, Knoxville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306993910 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 444 (Tennessee) | Secondary |
| 183500000X | Pharmacist | 24425 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Lee Smugor, DPM, PHARMD 8313 Oasis Ln, Knoxville, TN 37938-7400 Ph: (865) 556-5510 | Dr Daniel Lee Smugor, DPM, PHARMD 8313 Oasis Ln, Knoxville, TN 37938-7400 Ph: (865) 377-3174 |
News Archive
Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.
The World Health Organization reports that as of January 19, 2021, there are approximately 94 million cases of COVID-19 globally, with over 2 million deaths.
A University of Alberta research team has discovered that technology commonly used to decontaminate food industry equipment can also rid meat processing plants of lethal microbial material responsible for the human version of the ailment Mad Cow disease.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
› Verified 8 days ago